New findings show that individuals vaccinated against shingles exhibit a 20% reduced risk of dementia over a seven-year period compared to those unvaccinated, highlighting the importance of viral infection prevention in safeguarding cognitive health.
Shingles Vaccine Linked to Lower Risk of Dementia, New Study Reveals

Shingles Vaccine Linked to Lower Risk of Dementia, New Study Reveals
A recent study indicates that the shingles vaccine may significantly reduce the likelihood of developing dementia.
A groundbreaking study published in the journal Nature on April 2, 2025, reveals that vaccination against shingles can lower the risk of developing dementia by 20%. This research adds to the growing body of evidence indicating that preventing certain viral infections may have long-term benefits for brain health, potentially delaying cognitive decline.
The study's findings suggest that individuals who received the shingles vaccine were considerably less likely to experience dementia within a seven-year timeframe than those who opted not to receive the vaccination. "A 20% reduction in dementia risk is significant from a public health perspective, especially as we currently lack effective methods for delaying the onset of dementia," noted Dr. Paul Harrison, a professor of psychiatry at Oxford, who recognizes the implications of this research despite not being involved in the study.
While the longevity of the protective effects of the shingles vaccine remains under investigation, early indications suggest that it may offer one of the most promising preventative measures against dementia available. The shingles virus is a reactivation of the varicella-zoster virus, which causes chickenpox and can remain dormant in the body for years. As individuals age and their immune systems become weaker, the virus may reactivate, leading to shingles—a condition characterized by painful rashes and nerve pain that can persist long after the initial outbreak.
The potential link between shingles vaccination and reduced dementia risk opens new avenues for public health strategies aimed at mitigating cognitive decline in aging populations, as more research continues to explore how vaccination might contribute to brain health over the long term.